YUNG SHIN PHARM. IND. CO., LTD. Patent applications |
Patent application number | Title | Published |
20140357688 | METHOD FOR INHIBITING EZH2 EXPRESSION IN BREAST CANCER CELLS - The present invention is directed to a method for inhibiting the overexpression of EZH2 in breast cancer cells. The method comprises administering to breast cancer cells an effective amount of YC-1 (3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole), YC-1-succinate (succinic acid mono-[5-(1-benzyl-1H-indazol-3-yl)-furan-2-ylmethyl]ester), or a pharmaceutically acceptable salt thereof. The present invention is also directed to treating breast cancer comprising administering to a subject an effective amount of YC-1-succinate. | 12-04-2014 |
20130065957 | DICLOFENAC SALT OF TRAMADOL - The present invention relates to a compound of diclofenac-tramadol salt in 1:1 ratio and a pharmaceutical formulation comprising such compound. The present invention also relates to a method for treating a patient with moderate to moderately severe pain. The method comprises: identifying a patient suffering from moderate to moderately severe pain with pain intensity scale of 5-9, and administering to said patient the diclofenac-tramadol salt, in an effective amount. The method is particularly useful in treating postoperative pain after Cesarean, postoperative pain after non-Cesarean surgeries, cancer pain, osteoarthritis pain, or rheumatoid arthritis pain. | 03-14-2013 |
20090131681 | Novel fused pyrazolyl compounds having an aminoalkylcarbonyl group - A fused pyrazolyl compound having an anti-tumor potency of the following formula is synthesized: | 05-21-2009 |